Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
From Innovation to Standard of Care
Author(s): Jens Erik Nielsen Kudsk , Added: 3 months ago
Intracardiac echocardiography (ICE) has undergone a profound transformation in its role within left atrial appendage (LAA) closure – evolving from an experimental imaging adjunct to a clinically validated and increasingly adopted guidance strategy.In this on-demand educational discussion, Prof Jens Erik Nielsen-Kudsk (Aarhus University Hospital, DK) and Dr Sergio Berti (Fondazione Toscana G… View more

Electrophysiology & Arrhythmia

Imaging & Diagnostics
LAAC Not Non-Inferior to Medical Care in High-Risk AF
Added: 2 months ago Source:  Interventional Cardiology Review Journal
For patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, catheter-based left atrial appendage closure (LAAC) was not found to be non-inferior to physician-directed best medical care, according to the results of the CLOSURE-AF trial.¹MethodologyThe multicentre, randomised CLOSURE-AF trial was conducted in Germany to assess the effectiveness of LAAC compared with best… View more

Intervention

Prevention & Chronic Conditions
Left Atrial Appendage to Circumflex Fistula Following Amulet Device
Author(s): Timothy John Bagnall , Christopher James Broyd , David Hildick-Smith Added: 1 year ago

Intervention
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 7 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
ACC.26 Late-breaker Discussion: The CHAMPION-AF Trial
Author(s): Saibal Kar , Harriette Van Spall Added: 2 months ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more

Intervention

Anticoagulation
TSP in Patients with ASO
Author(s): Gerardo Lo Russo , Roberto Nerla , Angela Sanseviero , et al Added: 6 months ago

Intervention
ACC Congress 2026 Late-Breaking Science Collection
Author(s): Ann Marie Navar Added: 2 months ago
Keep up-to-date with our video collection from the American College of Cardiology's 75th Annual Scientific Session, bringing you the latest from late-breaking science, featured research, and clinical horizon sessions.Catch our congress preview and wrap-up in the NVM Cardiology Meeting Reflections series, alongside concise Expert Interviews with leading faculty distilling the key take-home… View more

Intervention

Vascular Disease and Surgery
Jacqueline Saw
Research Area(s) / Expertise: Job title: Clinical Associate Professor
Dr Jacqueline Saw is a Clinical Associate Professor in the Division of Cardiology at the University of British Columbia, Program Director for VGH Interventional Cardiology Fellowship Program and Head for VGH Cardiology Clinical Trials Research. Dr Saw obtained her her MD from the University of Ottawa. Her clinical expertise is in management of SCAD (spontaneous artery dissection), FMD … View more
Ole De Backer
Research Area(s) / Expertise: Job title: Professor of Medicine and Cardiology
Professor Ole De Backer is an internationally renowned interventional cardiologist based in Copenhagen, Denmark. He works at Rigshospitalet, Copenhagen University Hospital, where he is actively involved in the treatment of patients with complex structural heart disease. He has built an international reputation through his clinical expertise, research leadership, and commitment to innovation in… View more
AHA 24: The OPTION Trial
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more

Anticoagulation

Electrophysiology & Arrhythmia